Gabriele Schaefer
Molecular Oncology (United States)(US)
Publications by Year
Research Areas
HER2/EGFR in Cancer Research, Lung Cancer Treatments and Mutations, Monoclonal and Polyclonal Antibodies Research, Genomics, phytochemicals, and oxidative stress, Radiopharmaceutical Chemistry and Applications
Most-Cited Works
- → Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin.(1994)644 cited
- → Oncogenic ERBB3 Mutations in Human Cancers(2013)346 cited
- → A Two-in-One Antibody against HER3 and EGFR Has Superior Inhibitory Activity Compared with Monospecific Antibodies(2011)333 cited
- → The Intrinsic Contributions of Tyrosine, Serine, Glycine and Arginine to the Affinity and Specificity of Antibodies(2008)241 cited
- → Activation Mechanism of Oncogenic Deletion Mutations in BRAF, EGFR, and HER2(2016)214 cited
- → Dual Targeting of HER2-Positive Cancer with Trastuzumab Emtansine and Pertuzumab: Critical Role for Neuregulin Blockade in Antitumor Response to Combination Therapy(2013)194 cited
- → Hepatitis C Virus Induces Epidermal Growth Factor Receptor Activation via CD81 Binding for Viral Internalization and Entry(2012)140 cited
- → γ-Heregulin: a novel heregulin isoform that is an autocrine growth factor for the human breast cancer cell line, MDA-MB-175(1997)101 cited
- → Combined MEK and ERK inhibition overcomes therapy-mediated pathway reactivation in RAS mutant tumors(2017)92 cited
- → Noncovalent Wild-type–Sparing Inhibitors of EGFR T790M(2012)87 cited